<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36695893</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-0407</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Der Nervenarzt</Title><ISOAbbreviation>Nervenarzt</ISOAbbreviation></Journal><ArticleTitle>[Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence].</ArticleTitle><Pagination><StartPage>725</StartPage><EndPage>733</EndPage><MedlinePgn>725-733</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00115-022-01431-x</ELocationID><Abstract><AbstractText>Over the past 5&#xa0;years both media and scientific interest has surged regarding the disorder myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS), not least because of the clinically similar manifestation in long COVID or post-COVID. In this review we discuss the process of clinical diagnosis and randomized controlled therapeutic studies on ME/CFS, and the similarities or differences to long COVID and post-COVID. So far, neither clear pathophysiologically causal nor therapeutic evidence-based results on ME/CFS have been identified in the many years of scientific research. Given the evident psychiatric comorbidity rates in patients with a&#xa0;diagnosis of ME/CFS, a&#xa0;psychosomatic etiology of this syndrome should be considered. Furthermore, a&#xa0;precise and reliable diagnostic classification based on stricter criteria would benefit both pathophysiological and therapeutic research.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ludwig</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel&#xa0;18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olbert</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Tulln, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trimmel</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel&#xa0;18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seidel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel&#xa0;18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rommer</LastName><ForeName>Paulus S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel&#xa0;18-20, 1090, Wien, &#xd6;sterreich. paulus.rommer@meduniwien.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel&#xa0;18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struhal</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Tulln, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel&#xa0;18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Myalgische Enzephalomyelitis/chronisches Fatigue-Syndrom: eine &#xdc;bersicht zur aktuellen Evidenz.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nervenarzt</MedlineTA><NlmUniqueID>0400773</NlmUniqueID><ISSNLinking>0028-2804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>In den vergangenen 5&#xa0;Jahren hat sowohl das mediale als auch das wissenschaftliche Interesse an der Erkrankung myalgische Enzephalomyelitis/&#x201e;chronic fatigue syndrome&#x201c; (ME/CFS) signifikant zugenommen; nicht zuletzt auch durch die klinisch &#xe4;hnliche Manifestation im Rahmen von Long- oder Post-COVID. In dieser &#xdc;bersichtsarbeit diskutieren wir die klinische Diagnosestellung und therapeutische Studien zu ME/CFS sowie die Gemeinsamkeiten oder Unterschiede zu Long&#x2011;/Post-COVID. Bisher liegen weder pathophysiologisch eindeutig kausale noch therapeutisch evidenzbasierte Ergebnisse in der langj&#xe4;hrigen wissenschaftlichen Forschung zu ME/CFS vor. Nicht zuletzt aufgrund der relevanten psychiatrischen Komorbidit&#xe4;tsrate beim ME/CFS ist nach der aktuellen Datenlage eine psychosomatische &#xc4;tiologie der Erkrankung zu diskutieren. Des Weiteren k&#xf6;nnte sich eine genauere und sichere Diagnosestellung anhand strikterer Diagnosekriterien auf die weitere Forschung und vor allem hinsichtlich Therapien positiv auswirken.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Evidence</Keyword><Keyword MajorTopicYN="N">POTS</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Psychosomatic</Keyword><Keyword MajorTopicYN="N">Randomized-controlled trials</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36695893</ArticleId><ArticleId IdType="pmc">PMC9875188</ArticleId><ArticleId IdType="doi">10.1007/s00115-022-01431-x</ArticleId><ArticleId IdType="pii">10.1007/s00115-022-01431-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>[Ng206] NG . Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001;134:868&#x2013;881. doi: 10.7326/0003-4819-134-9_Part_2-200105011-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-134-9_Part_2-200105011-00011</ArticleId><ArticleId IdType="pubmed">11346323</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbass A, Town J, Holmes H, et al. Short-term psychodynamic psychotherapy for functional somatic disorders: A meta-analysis of randomized controlled trials. Psychother Psychosom. 2020;89:363&#x2013;370. doi: 10.1159/000507738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507738</ArticleId><ArticleId IdType="pubmed">32428905</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, et al. Long COVID, a&#xa0;comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome: The human herpesviruses are back! Biomolecules. 2021;11(2):185. doi: 10.3390/biom11020185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11020185</ArticleId><ArticleId IdType="pmc">PMC7912523</ArticleId><ArticleId IdType="pubmed">33572802</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker R, Shaw EJ. Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ. 2007;335:446&#x2013;448. doi: 10.1136/bmj.39302.509005.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39302.509005.AE</ArticleId><ArticleId IdType="pmc">PMC1962830</ArticleId><ArticleId IdType="pubmed">17762037</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk JN. Chronic fatigue syndrome prevalence is grossly overestimated using oxford criteria compared to centers for disease control (Fukuda) criteria in a&#xa0;U.S. population study. Fatigue. 2017;5:215&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6407870</ArticleId><ArticleId IdType="pubmed">30854252</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand. 1990;82:209&#x2013;216. doi: 10.1111/j.1600-0404.1990.tb04490.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1990.tb04490.x</ArticleId><ArticleId IdType="pubmed">2270749</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole M, Moya A, De Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883&#x2013;1948. doi: 10.1093/eurheartj/ehy037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy037</ArticleId><ArticleId IdType="pubmed">29562304</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole M, Moya A, De Lange FJ, et al. Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:e43&#x2013;e80. doi: 10.1093/eurheartj/ehy071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy071</ArticleId><ArticleId IdType="pubmed">29562291</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronstein C. On psychosomatics: the search for meaning. Int J Psychoanal. 2011;92:173&#x2013;195. doi: 10.1111/j.1745-8315.2010.00388.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-8315.2010.00388.x</ArticleId><ArticleId IdType="pubmed">21323885</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MM, Bell DS, Jason LA, et al. Understanding long-term outcomes of chronic fatigue syndrome. J Clin Psychol. 2012;68:1028&#x2013;1035. doi: 10.1002/jclp.21880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jclp.21880</ArticleId><ArticleId IdType="pmc">PMC3940158</ArticleId><ArticleId IdType="pubmed">22753044</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, et al. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: A&#xa0;prospective multidomain observational study. J Neurol. 2022;269:587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Saez-Francas N, Santillo D, et al. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: All roads lead to Rome. Br J Pharmacol. 2017;174:345&#x2013;369. doi: 10.1111/bph.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Segundo MJ, Lacasa M, et al. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind, placebo-controlled trial. Nutrients. 2021;13(8):2658. doi: 10.3390/nu13082658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13082658</ArticleId><ArticleId IdType="pmc">PMC8399248</ArticleId><ArticleId IdType="pubmed">34444817</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Zaragoza MC, Lopez-Vilchez I, et al. Effect of melatonin plus zinc supplementation on fatigue perception in myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. Antioxidants (Basel) 2021;10(7):1010. doi: 10.3390/antiox10071010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10071010</ArticleId><ArticleId IdType="pmc">PMC8300692</ArticleId><ArticleId IdType="pubmed">34201806</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Goldsmith KA, White PD, et al. Rehabilitative therapies for chronic fatigue syndrome: A&#xa0;secondary mediation analysis of the PACE trial. Lancet Psychiatry. 2015;2(2):141&#x2013;152. doi: 10.1016/S2215-0366(14)00069-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(14)00069-8</ArticleId><ArticleId IdType="pubmed">26359750</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313:1101&#x2013;1102. doi: 10.1001/jama.2015.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell SJ, Mathias JL. Cognitive functioning in chronic fatigue syndrome: a&#xa0;meta-analysis. Psychol Med. 2010;40:1253&#x2013;1267. doi: 10.1017/S0033291709992054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291709992054</ArticleId><ArticleId IdType="pubmed">20047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Courjaret J, Schotte CK, Wijnants H, et al. Chronic fatigue syndrome and DSM-IV personality disorders. J Psychosom Res. 2009;66:13&#x2013;20. doi: 10.1016/j.jpsychores.2008.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2008.07.001</ArticleId><ArticleId IdType="pubmed">19073288</ArticleId></ArticleIdList></Reference><Reference><Citation>Flottorp SA, Brurberg KG, Fink P, et al. New NICE guideline on chronic fatigue syndrome: more ideology than science? Lancet. 2022;399:611&#x2013;613. doi: 10.1016/S0140-6736(22)00183-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00183-0</ArticleId><ArticleId IdType="pubmed">35151381</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O, Bruland O, Risa K, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One. 2011;6:e26358. doi: 10.1371/journal.pone.0026358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026358</ArticleId><ArticleId IdType="pmc">PMC3198463</ArticleId><ArticleId IdType="pubmed">22039471</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O, Mella O. Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a&#xa0;preliminary case series. BMC Neurol. 2009;9:28. doi: 10.1186/1471-2377-9-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-9-28</ArticleId><ArticleId IdType="pmc">PMC2711959</ArticleId><ArticleId IdType="pubmed">19566965</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O, Rekeland IG, Lien K, et al. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2019;170:585&#x2013;593. doi: 10.7326/M18-1451.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1451</ArticleId><ArticleId IdType="pubmed">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O, Risa K, Lunde S, et al. B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLoS ONE. 2015;10:e0129898. doi: 10.1371/journal.pone.0129898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129898</ArticleId><ArticleId IdType="pmc">PMC4488509</ArticleId><ArticleId IdType="pubmed">26132314</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Nojima J, Kajimoto O, et al. Ubiquinol-10 supplementation improves autonomic nervous function and cognitive function in chronic fatigue syndrome. Biofactors. 2016;42:431&#x2013;440. doi: 10.1002/biof.1293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1293</ArticleId><ArticleId IdType="pubmed">27125909</ArticleId></ArticleIdList></Reference><Reference><Citation>Geffen D. An outbreak of encephalomyelitis in the Royal Free Hospital Group, 1955. Public Health. 1957;71:13&#x2013;24. doi: 10.1016/S0033-3506(57)80004-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0033-3506(57)80004-3</ArticleId><ArticleId IdType="pubmed">13420297</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotaas ME, Stiles TC, Bjorngaard JH, et al. Cognitive behavioral therapy improves physical function and fatigue in mild and moderate chronic fatigue syndrome: A consecutive randomized controlled trial of standard and short interventions. Front Psychiatry. 2021;12:580924. doi: 10.3389/fpsyt.2021.580924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.580924</ArticleId><ArticleId IdType="pmc">PMC8071989</ArticleId><ArticleId IdType="pubmed">33912079</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey SB, Wadsworth M, Wessely S, et al. The relationship between prior psychiatric disorder and chronic fatigue: Evidence from a&#xa0;national birth cohort study. Psychol Med. 2008;38:933&#x2013;940. doi: 10.1017/S0033291707001900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291707001900</ArticleId><ArticleId IdType="pmc">PMC3196526</ArticleId><ArticleId IdType="pubmed">17976252</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a&#xa0;working case definition. Ann Intern Med. 1988;108:387&#x2013;389. doi: 10.7326/0003-4819-108-3-387.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-108-3-387</ArticleId><ArticleId IdType="pubmed">2829679</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse A, Nikolaus S, Wiborg JF, et al. Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome. J Psychosom Res. 2017;97:45&#x2013;51. doi: 10.1016/j.jpsychores.2017.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2017.03.016</ArticleId><ArticleId IdType="pubmed">28606498</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse A, Worm-Smeitink M, Bleijenberg G, et al. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial. Br J Psychiatry. 2018;212:112&#x2013;118. doi: 10.1192/bjp.2017.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2017.22</ArticleId><ArticleId IdType="pubmed">29436329</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempke S, Van Den Eede F, Schotte C, et al. Prevalence of DSM-IV personality disorders in patients with chronic fatigue syndrome: a&#xa0;controlled study. Int J Behav Med. 2013;20:219&#x2013;228. doi: 10.1007/s12529-012-9273-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12529-012-9273-y</ArticleId><ArticleId IdType="pubmed">23065435</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, Franke C, Gl&#xf6;ckl RGC, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick R. S1-Leitlinie Post-COVID/Long-COVID. AWMF Online. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA. 2019;322:499&#x2013;500. doi: 10.1001/jama.2019.8312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.8312</ArticleId><ArticleId IdType="pubmed">31276153</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L, Brurberg KG, Odgaard-Jensen J, et al. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2016;12:CD003200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6473631</ArticleId><ArticleId IdType="pubmed">27995604</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med. 1990;89:561&#x2013;568. doi: 10.1016/0002-9343(90)90173-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(90)90173-B</ArticleId><ArticleId IdType="pubmed">2146875</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, et al. Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariman A, Delesie L, Tobback E, et al. Undiagnosed and comorbid disorders in patients with presumed chronic fatigue syndrome. J Psychosom Res. 2013;75:491&#x2013;496. doi: 10.1016/j.jpsychores.2013.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2013.07.010</ArticleId><ArticleId IdType="pubmed">24182640</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A, Chalder T, Rief W, et al. The relationship between chronic fatigue and somatization syndrome: a&#xa0;general population survey. J Psychosom Res. 2007;63:147&#x2013;156. doi: 10.1016/j.jpsychores.2007.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2007.05.007</ArticleId><ArticleId IdType="pubmed">17662751</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuki S, Eisenach JH, Johnson CP, et al. Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety. J Appl Physiol. 2007;102:896&#x2013;903. doi: 10.1152/japplphysiol.00927.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00927.2006</ArticleId><ArticleId IdType="pubmed">17110507</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcevedy CP, Beard AW. Concept of benign myalgic encephalomyelitis. Br Med J. 1970;1:11&#x2013;15. doi: 10.1136/bmj.1.5687.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.5687.11</ArticleId><ArticleId IdType="pmc">PMC1700895</ArticleId><ArticleId IdType="pubmed">5411596</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcevedy CP, Beard AW. Royal Free epidemic of 1955: a&#xa0;reconsideration. Br Med J. 1970;1:7&#x2013;11. doi: 10.1136/bmj.1.5687.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.5687.7</ArticleId><ArticleId IdType="pmc">PMC1700894</ArticleId><ArticleId IdType="pubmed">5411611</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Kogelnik AM, Bhangoo M, et al. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a&#xa0;subset of patients with chronic fatigue syndrome. J Med Virol. 2013;85:2101&#x2013;2109. doi: 10.1002/jmv.23713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23713</ArticleId><ArticleId IdType="pubmed">23959519</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller AE, Tveito K, Bakken IJ, et al. Potential causal factors of CFS/ME: a&#xa0;concise and systematic scoping review of factors researched. J Transl Med. 2020;18:484. doi: 10.1186/s12967-020-02665-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02665-6</ArticleId><ArticleId IdType="pmc">PMC7734915</ArticleId><ArticleId IdType="pubmed">33317576</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Lin JS, Lange G, et al. The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome. Ann Med. 2019;51:371&#x2013;378. doi: 10.1080/07853890.2019.1683601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2019.1683601</ArticleId><ArticleId IdType="pmc">PMC7877877</ArticleId><ArticleId IdType="pubmed">31642345</ArticleId></ArticleIdList></Reference><Reference><Citation>Nater UM, Lin JM, Maloney EM, et al. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom Med. 2009;71:557&#x2013;565. doi: 10.1097/PSY.0b013e31819ea179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e31819ea179</ArticleId><ArticleId IdType="pubmed">19414619</ArticleId></ArticleIdList></Reference><Reference><Citation>Norcliffe-Kaufmann L, Palma JA, Martinez J, et al. Fear conditioning as a&#xa0;pathogenic mechanism in the postural tachycardia syndrome. Brain. 2022;145(11):3763&#x2013;3769. doi: 10.1093/brain/awac249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac249</ArticleId><ArticleId IdType="pmc">PMC10200284</ArticleId><ArticleId IdType="pubmed">35802513</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;dowd H, Gladwell P, Rogers CA, et al. Cognitive behavioural therapy in chronic fatigue syndrome: a&#xa0;randomised controlled trial of an outpatient group programme. Health Technol Assess. 2006;10:1&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">17014748</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto LE, Raj SR, Peltier A, et al. Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes. Clin Sci (Lond) 2012;122:183&#x2013;192. doi: 10.1042/CS20110200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20110200</ArticleId><ArticleId IdType="pmc">PMC3203411</ArticleId><ArticleId IdType="pubmed">21906029</ArticleId></ArticleIdList></Reference><Reference><Citation>Owe JF, Naess H, Gjerde IO, et al. Investigation of suspected chronic fatigue syndrome/myalgic encephalopathy. Tidsskr Nor Laegeforen. 2016;136:227&#x2013;232. doi: 10.4045/tidsskr.15.0229.</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.15.0229</ArticleId><ArticleId IdType="pubmed">26860382</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med. 1990;89:554&#x2013;560. doi: 10.1016/0002-9343(90)90172-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(90)90172-A</ArticleId><ArticleId IdType="pubmed">2239975</ArticleId></ArticleIdList></Reference><Reference><Citation>Pine F. The psychoanalytic dictionary: a&#xa0;position paper on diversity and its unifiers. J Am Psychoanal Assoc. 2006;54:463&#x2013;491. doi: 10.1177/00030651060540021701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00030651060540021701</ArticleId><ArticleId IdType="pubmed">16773818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekeland IG, Fossa A, Lande A, et al. Intravenous cyclophosphamide in myalgic encephalomyelitis/chronic fatigue syndrome. An open-label phase II study. Front Med (Lausanne) 2020;7:162. doi: 10.3389/fmed.2020.00162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00162</ArticleId><ArticleId IdType="pmc">PMC7201056</ArticleId><ArticleId IdType="pubmed">32411717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Montero-Mateo R, et al. Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front Immunol. 2021;12:656797. doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, et al. Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol. 2022;91:150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczak S, Honig A, Nicolson NA, et al. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology. 2002;27:834&#x2013;842. doi: 10.1016/S0893-133X(02)00345-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0893-133X(02)00345-7</ArticleId><ArticleId IdType="pubmed">12431857</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18(4):2030. doi: 10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042030</ArticleId><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Strayer DR, Carter WA, Stouch BC, et al. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One. 2012;7:e31334. doi: 10.1371/journal.pone.0031334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031334</ArticleId><ArticleId IdType="pmc">PMC3303772</ArticleId><ArticleId IdType="pubmed">22431963</ArticleId></ArticleIdList></Reference><Reference><Citation>Strayer DR, Young D, Mitchell WM. Effect of disease duration in a&#xa0;randomized phase III trial of rintatolimod, an immune modulator for myalgic encephalomyelitis/chronic fatigue syndrome. PLoS ONE. 2020;15:e0240403. doi: 10.1371/journal.pone.0240403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240403</ArticleId><ArticleId IdType="pmc">PMC7595369</ArticleId><ArticleId IdType="pubmed">33119613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taerk G, Gnam W. A psychodynamic view of the chronic fatigue syndrome. The role of object relations in etiology and treatment. Gen Hosp Psychiatry. 1994;16:319&#x2013;325. doi: 10.1016/0163-8343(94)90018-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0163-8343(94)90018-3</ArticleId><ArticleId IdType="pubmed">7995502</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs RD, Brignole M, Falup-Pecurariu C, et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN) Auton Neurosci. 2021;233:102792. doi: 10.1016/j.autneu.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102792</ArticleId><ArticleId IdType="pubmed">33752997</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. NICE backtracks on graded exercise therapy and CBT in draft revision to CFS guidance. BMJ. 2020;371:m4356. doi: 10.1136/bmj.m4356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4356</ArticleId><ArticleId IdType="pubmed">33172928</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner-Stokes L, Wade DT. Updated NICE guidance on chronic fatigue syndrome. BMJ. 2020;371:m4774. doi: 10.1136/bmj.m4774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4774</ArticleId><ArticleId IdType="pubmed">33328173</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderlind WM, Rabinovitz BB, Miao IY, et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: Implications for treatment. Curr Opin Psychiatry. 2021;34:420&#x2013;433. doi: 10.1097/YCO.0000000000000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC8183238</ArticleId><ArticleId IdType="pubmed">34016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom Med. 2004;66:276&#x2013;282. doi: 10.1097/01.psy.0000116249.60477.e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.psy.0000116249.60477.e9</ArticleId><ArticleId IdType="pubmed">15039515</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent A, Brimmer DJ, Whipple MO, et al. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87:1145&#x2013;1152. doi: 10.1016/j.mayocp.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.08.015</ArticleId><ArticleId IdType="pmc">PMC3518652</ArticleId><ArticleId IdType="pubmed">23140977</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med. 1997;103:38&#x2013;43. doi: 10.1016/S0002-9343(97)90045-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(97)90045-0</ArticleId><ArticleId IdType="pubmed">9236484</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren G, Mckendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a&#xa0;placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand. 1999;99:112&#x2013;116. doi: 10.1111/j.1600-0404.1999.tb00667.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb00667.x</ArticleId><ArticleId IdType="pubmed">10071170</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Goldsmith KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a&#xa0;randomised trial. Lancet. 2011;377:823&#x2013;836. doi: 10.1016/S0140-6736(11)60096-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60096-2</ArticleId><ArticleId IdType="pmc">PMC3065633</ArticleId><ArticleId IdType="pubmed">21334061</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Basso MR, Naini SM, et al. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6&#xa0;months post-infection Part 1: Cognitive functioning. Clin Neuropsychol. 2022;36(4):806&#x2013;828. doi: 10.1080/13854046.2022.2030412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2022.2030412</ArticleId><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Naini SM, Basso MR, et al. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6&#xa0;months post-infection part 2: Psychological functioning. Clin Neuropsychol. 2022;36(4):829&#x2013;847. doi: 10.1080/13854046.2022.2030411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2022.2030411</ArticleId><ArticleId IdType="pubmed">35098861</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Coronavirus disease (COVID-19): Post COVID-19 condition. Genf: World Health Organization; 2021.</Citation></Reference><Reference><Citation>WHO . Systematisches Verzeichnis, Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme. 2022.</Citation></Reference><Reference><Citation>Wilshire CE, Kindlon T, Courtney R, et al. Rethinking the treatment of chronic fatigue syndrome&#x2014;a reanalysis and evaluation of findings from a&#xa0;recent major trial of graded exercise and CBT. BMC Psychol. 2018;6:6. doi: 10.1186/s40359-018-0218-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40359-018-0218-3</ArticleId><ArticleId IdType="pmc">PMC5863477</ArticleId><ArticleId IdType="pubmed">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer M, Szepanowski F, Tovar M, et al. Post-COVID-19 syndrome is rarely associated with damage of the nervous system: Findings from a&#xa0;prospective observational cohort study in 171 patients. Neurol Ther. 2022;11(4):1637&#x2013;1657. doi: 10.1007/s40120-022-00395-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-022-00395-z</ArticleId><ArticleId IdType="pmc">PMC9417089</ArticleId><ArticleId IdType="pubmed">36028604</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>